Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study

Favorable efficacy and safety profiles have been demonstrated for abatacept in patients with rheumatoid arthritis (RA) in randomized controlled trials, but these data require validation during long-term follow-ups in routine clinical practice. This study explored long-term safety and retention rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhovens, R., Connolly, S. E., Margaux, J., Vanden Berghe, M., Maertens, M., Van den Berghe, M., Elbez, Y., Chartier, M., Baeke, F., Robert, S., Malaise, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Cohort Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371673/
https://www.ncbi.nlm.nih.gov/pubmed/32556473
http://dx.doi.org/10.1007/s00296-020-04619-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371673/
https://www.ncbi.nlm.nih.gov/pubmed/32556473
http://dx.doi.org/10.1007/s00296-020-04619-z

Ejemplares similares